|
GLMD Galmed Pharmaceuticals Ltd 1595353 |
| Income Statement |
|
Net Income
|
2025-12-31
|
$-10,309,000.00 |
| Balance Sheet |
|
Current Assets
|
$18,627,000.00 |
|
Assets
|
$18,627,000.00 |
|
Current Liabilities
|
$2,845,000.00 |
|
Equity
|
$15,782,000.00 |
|
Shares Out
|
6581390.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,315,000.00 |
|
Investing Cash Flow
|
$-3,375,000.00 |
| Market Analysis |
Market Cap
|
$3,948,834.00 |
|
Price
|
$0.60 |
|
BVPS
|
2.40 |
|
PB
|
0.25 |
|
EPS
|
2.39 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GLMD documents filed with the SEC.
GLMD Filings
Clear
